Related references
Note: Only part of the references are listed.Fates of CD8+ T cells in Tumor Microenvironment
Nomathamsanqa Resegofetse Maimela et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2019)
Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells
Varun Sasidharan Nair et al.
IMMUNOLOGY AND CELL BIOLOGY (2018)
CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions
Masao Hashimoto et al.
ANNUAL REVIEW OF MEDICINE, VOL 69 (2018)
Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity
Sabine Hoves et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Anti-PD-1/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking
David Taggart et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Association of tumour-infiltrating regulatory T cells with adverse outcomes in dogs with malignant tumours
K. Sakai et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2018)
Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC)
Young Kwang Chae et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, efficacy, and Limitations
Judith A. Seidel et al.
FRONTIERS IN ONCOLOGY (2018)
SEA-CD40, a non-fucosylated CD40 agonist: Interim results from a phase 1 study in advanced solid tumors.
Juneko E. Grilley-Olson et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Radiation and Local Anti-CD40 Generate an Effective in situ Vaccine in Preclinical Models of Pancreatic Cancer
Sayeda Yasmin-Karim et al.
FRONTIERS IN IMMUNOLOGY (2018)
Long-term outcomes of a phase I study of agonist CD40 antibody and CTLA-4 blockade in patients with metastatic melanoma
David L. Bajor et al.
ONCOIMMUNOLOGY (2018)
Tumor infiltrating lymphocytes in lymph node metastases of stage III melanoma correspond to response and survival in nine patients treated with ipilimumab at the time of stage IV disease
Stefan Diem et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy
Yuchen Fan et al.
NANO LETTERS (2017)
Combination of CD40 Agonism and CSF-1R Blockade Reconditions Tumor-Associated Macrophages and Drives Potent Antitumor Immunity
Karla R. Wiehagen et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Agonistic CD40 mAb-Driven IL12 Reverses Resistance to Anti-PD1 in a T-cell-Rich Tumor
Shin Foong Ngiow et al.
CANCER RESEARCH (2016)
In situ vaccination for the treatment of cancer
Linda Hammerich et al.
IMMUNOTHERAPY (2016)
Low-Intensity Focused Ultrasound Induces Reversal of Tumor-Induced T Cell Tolerance and Prevents Immune Escape
Sanmay Bandyopadhyay et al.
JOURNAL OF IMMUNOLOGY (2016)
The Growing Burden of Invasive Melanoma: Projections of Incidence Rates and Numbers of New Cases in Six Susceptible Populations through 2031
David C. Whiteman et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumour immunity
Caroline Baer et al.
NATURE CELL BIOLOGY (2016)
Interaction between Treg cells and tumor-associated macrophages in the tumor microenvironment of epithelial ovarian cancer
Qinyi Zhu et al.
ONCOLOGY REPORTS (2016)
Current clinical trials testing the combination of immunotherapy with radiotherapy
Josephine Kang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Local hyperthermia combined with radiotherapy and-/or chemotherapy: Recent advances and promises for the future
N. R. Datta et al.
CANCER TREATMENT REVIEWS (2015)
In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf
Linda Hammerich et al.
MOLECULAR ONCOLOGY (2015)
Systemic Agonistic Anti-CD40 Treatment of Tumor-Bearing Mice Modulates Hepatic Myeloid-Suppressive Cells and Causes Immune-Mediated Liver Damage
Jose Medina-Echeverz et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Local hyperthermia treatment of tumors induces CD8+ T cell-mediated resistance against distal and secondary tumors
Seiko Toraya-Brown et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)
Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing
Sofia R. Gameiro et al.
ONCOTARGET (2014)
Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death
Encouse B. Golden et al.
ONCOIMMUNOLOGY (2014)
Targeting macrophages rescues age-related immune deficiencies in C57BL/6J geriatric mice
Connie Jackaman et al.
AGING CELL (2013)
Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
Wei Liao et al.
IMMUNITY (2013)
Magnetic Resonance Guided High-Intensity Focused Ultrasound Mediated Hyperthermia Improves the Intratumoral Distribution of Temperature-Sensitive Liposomal Doxorubicin
Mariska de Smet et al.
INVESTIGATIVE RADIOLOGY (2013)
Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
Silvia C. Formenti et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Elevated granzyme B in cytotoxic lymphocytes is a signature of immune activation in hemophagocytic lymphohistiocytosis
Sabine Mellor-Heineke et al.
FRONTIERS IN IMMUNOLOGY (2013)
Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma
Stefanie Regine Dannenmann et al.
ONCOIMMUNOLOGY (2013)
An immune-active tumor microenvironment favors clinical response to ipilimumab
Rui-Ru Ji et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Overcoming Limitations in Nanoparticle Drug Delivery: Triggered, Intravascular Release to Improve Drug Penetration into Tumors
Ashley A. Manzoor et al.
CANCER RESEARCH (2012)
T-cell-independent Antitumor Effects of CD40 Ligation
Alexander L. Rakhmilevich et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2012)
Image-guided drug delivery with magnetic resonance guided high intensity focused ultrasound and temperature sensitive liposomes in a rabbit Vx2 tumor model
Ashish Ranjan et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Radiotherapy Promotes Tumor-Specific Effector CD8+ T Cells via Dendritic Cell Activation
Anurag Gupta et al.
JOURNAL OF IMMUNOLOGY (2012)
M-HIFU Inhibits Tumor Growth, Suppresses STAT3 Activity and Enhances Tumor Specific Immunity in a Transplant Tumor Model of Prostate Cancer
Xiaoyi Huang et al.
PLOS ONE (2012)
The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu mice
Ronald P. Gladue et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Local Activation of CD8 T Cells and Systemic Tumor Eradication without Toxicity via Slow Release and Local Delivery of Agonistic CD40 Antibody
Marieke F. Fransen et al.
CLINICAL CANCER RESEARCH (2011)
A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
Omid Hamid et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Gene Signature in Melanoma Associated With Clinical Activity A Potential Clue to Unlock Cancer Immunotherapy
Thomas F. Gajewski et al.
CANCER JOURNAL (2010)
Macrophage Diversity Enhances Tumor Progression and Metastasis
Bin-Zhi Qian et al.
CELL (2010)
T-cell exhaustion: characteristics, causes and conversion
John S. Yi et al.
IMMUNOLOGY (2010)
Boosting high-intensity focused ultrasound-induced anti-tumor immunity using a sparse-scan strategy that can more effectively promote dendritic cell maturation
Fang Liu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Enhancement of antitumor vaccine in ablated hepatocellular carcinoma by high-intensity focused ultrasound
Ying Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Heat Shock Protein 70, Released from Heat-Stressed Tumor Cells, Initiates Antitumor Immunity by Inducing Tumor Cell Chemokine Production and Activating Dendritic Cells via TLR4 Pathway
Taoyong Chen et al.
JOURNAL OF IMMUNOLOGY (2009)
PD-1-Mediated Suppression of IL-2 Production Induces CD8+ T Cell Anergy In Vivo
Shunsuke Chikuma et al.
JOURNAL OF IMMUNOLOGY (2009)
CD40 ligation in vivo can induce T cell independent antitumor effects even against immunogenic tumors
Alexander L. Rakhmilevich et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Investigation of HIFU-induced anti-tumor immunity in a murine tumor model
Zhenlin Hu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
Temporal progression of viral replication and gross and histological lesions in Balb/c mice inoculated epidermally with Saimiriine herpesvirus 1 (SaHV-1)
MA Breshears et al.
JOURNAL OF COMPARATIVE PATHOLOGY (2005)
Therapeutic effectiveness of recombinant cancer vaccines is associated with a prevalent T-cell receptor α usage by melanoma-speciflc CD8+ T lymphocytes
R De Palma et al.
CANCER RESEARCH (2004)
Anti-CD40 monoclonal antibody therapy in combination with irradiation results in a CD8 T-cell-dependent immunity to B-cell lymphoma
J Honeychurch et al.
BLOOD (2003)
Share Paper
